Elevated HLA-G levels in HCC patients are linked to worse survival, indicating its potential as a prognostic marker. HCC patients with viral hepatitis or steatotic liver disease show significantly ...
Human leukocyte antigen-G (HLA-G) represents a pivotal non-classical major histocompatibility complex class I molecule with unique immunomodulatory properties. Research has revealed that HLA-G plays a ...
SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's ...
HLA-G gene harbors certain polymorphic variations that can potentially impact its biological activity, and therefore, may confer a risk for recurrent pregnancy loss (RPL). This study aimed to analyze ...
Correlation between biomarkers and treatment outcomes in diverse cancers: A meta-analysis of phase I and II immunotherapy clinical trials. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
HLA-G gene harbors certain polymorphic variations that can potentially impact its biological activity, and therefore, may confer a risk for recurrent pregnancy loss (RPL). This study aimed to analyze ...
Invectys Inc. and CTMC, a joint venture between MD Anderson Cancer Center and National Resilience Inc., have announced FDA clearance of an IND application for a phase I/IIa study of IVS-3001, Invectys ...
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform Esco Aster, a vertically integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results